Skip Navigation Links
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
Overall Recruitment Status: Active, currently enrolling
 
Official Title
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
 
Region Sponsors
Northwest
National Cancer Institute (NCI)
 
Acronym KP IRB No.
Connect KPNW-1725577
 
Study Type Phase
Prospective Cohort Study with Direct Patient Contact
 
Study Population Description
Patients or members of participating health care organizations around the U.S. including KPNW
 
Purpose
Working Together to Prevent Cancer The Connect for Cancer Prevention Study wants to better understand the causes of cancer and how to prevent it. We are asking you to join Connect so that we can study the health and behavior patterns that may affect cancer risk. Together, we can change the future of cancer prevention. .
 
Detailed Description
Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with several health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk. Objective: To study and better understand the causes of cancer and to find new ways to prevent it. Eligibility: The study will include 200,000 adults who get their health care from a partner health care system, are between 30 and 70 years old at enrollment, and have never had cancer. People remain eligible to join if they have or once had non-melanoma skin cancer, or a condition that may raise cancer risk (such as ductal carcinoma in situ, or DCIS). Design: Eligible recruits can sign up for Connect online by creating an account on the MyConnect using their email address or phone number. After creating an account, they will complete the informed consent process. All information shared through MyConnect is secure to protect participant privacy. After joining the study, participants will be asked to answer online health surveys a few times a year, donate samples of blood, urine, and saliva every two to three years, and safely share access to their electronic health records with Connect. In the future, participants may donate unused samples that are collected at clinical visits, like tissue, stool, or blood, and may mail in samples collected at home. Participants may also share information from personal health trackers, like wearable devices or apps. This information will help researchers study the health and behavior patterns that may affect cancer risk. It takes time to understand the causes of cancer, so Connect will go on for many years. The longer people participate, the more researchers may learn. Participants can leave the study at any time. Learn more about Connect by visiting cancer.gov/connectstudy.
 
Gender Age Limit
Male & Female 30 - 70 years
 
Inclusion Criteria
  • Patients or members of participating Health Care Organization including KPNW at the time of enrollment
  • Age between 40 and 65 years old at study invitation
 
Exclusion Criteria
  • Individuals with a history of invasive cancer (other than non-melanoma skin cancer)
  • Individuals with known cognitive impairment documented in their medical record

 
Keywords and/or Specific Medical Conditions
  • Blood
  • Urine
  • Genetics
  • Oncology (Adult)
  • Medical Conditions
  • Preventative Medicine
  • Natural History
  • Risk Factors
  • Pathology
 
KP Clinical Facility
  • KPNW Center for Health Research
 
Clinical Area
  • Genetics
  • Oncology (Adult)
  • Pathology
  • Preventative Medicine


Principal Investigator:
Mark A Schmidt, PhD
Contact Information:
- Kristin R Muessig, MS
-503-335-2400
-Kristin.R.Muessig@kpchr.org
-KPNW Center for Health Research


smilelady1
Do you want to receive
Email Alerts?

Sign Up Here!





Regional Research Sites: